MTVA MetaVia, Inc. Net Income

Official company branding of MetaVia (MTVA)

MetaVia Inc (MTVA) is an academic biotech firm that attracts scientists to develop dementia treatments through a grant system. The company's aggregate profit on this chart reflects revenue dynamics, where -0.01 shows the current value of the metric. The high scalability of a single molecule promises colossal profits, while the modernization of contract plants guarantees the stable synthesis of innovative neuropreparations.

Net Income: metaviatx.com (MTVA) for 11/30/2024 - 10/29/2026

Comprehensive metric breakdowns and analytics for metaviatx.com (MTVA)

- stock value and consensus price forecast:
Market Price MetaVia|MTVA - Price Target Chart
- market capitalization data:
Market Valuation MetaVia|MTVA - Enterprise Value
- company book value details:
Net Asset Value per Share MetaVia|MTVA - Company Net Assets|Market Cap to Book Value Multiple metaviatx.com|MTVA - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital MetaVia Inc|MTVA - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity MetaVia|MTVA - Company Aggregate Debts|Debts to Net Assets MetaVia|MTVA - Company Long-Term Debts|Company Short-Term Debts MetaVia|Intermediate Coverage Ratio metaviatx.com
- company profitability and valuation multiples indicators:
MTVA - Net Profit
Fundamental valuation:MTVA - MetaVia, Inc.
Manufactured product of MetaVia

The indicator is calculated as the difference between total revenues and all operating expenses, reflecting the final efficiency of value generation net of tax liabilities. This metric allows for an assessment of the financial stability of MetaVia Inc. (MTVA) considering the delegation of drug synthesis to external CDMO facilities, which minimizes capital expenditures and is clearly evidenced by the company's real profit trends.

Direct competitors

Company Net Income Biogen Idec (BIIB)|Company Net Income Neurocrine Biosciences|Net Income regencellbioscience.com (RGC)|Net Profit AXSM|ACAD - Company Net Income|Xenon Pharmaceuticals Inc - Net Income|Profit After Payment of Taxes VKTX (Viking Therapeutics Corp)|Supernus Pharmaceuticals - Net Profit|CPRX - Net Profit|DNLI (Denali Therapeutics Inc.) - Net Income|HRMY (Harmony Biosciences Inc) - Company Net Income|BHVN (Biohaven Pharmaceutical) - Net Profit|Amylyx Corp (AMLX) - Net Financial Result|Net Profit TRVI|Net Profit praxismedicines.com (PRAX)|Anavex Life Sciences Corp. - Net Income|Final Profit CBLL|Prothena Biosciences - Net Profit|Net Financial Result Alector, Inc. ALEC|Annexon, Inc. (ANNX) - Company Net Income|Company Profit OMER|NGNE (Neurogene) - Net Profit|Net Income AC Immune S.A. (ACIU)|Company Net Income Voyager Pharma (VYGR)|Net Income Neumora Corp NMRA|Scilex Holding Company - Net Income|Profit After Payment of Taxes TVGN (tevogen.com)|ACOG: Net Income|CGTX: Company Net Income|IKT: Net Profit|Cassava Pharma (SAVA) - Net Profit|Company Net Income Assertio Holdings|Company Profit COYA (Coya)|Net Profit VTGN|OVID - Company Net Income|Acumen Pharma - Net Income|Net Profit CervoMed Corporation CRVO|ATHE - Company Net Income|Final Profit CLNN (Clene Inc.)|pepgen.com (PEPG) - Company Net Income|Company Net Income jupiterneurosciences.com (JUNS)|Company Net Income Relmada|Net Income Annovis Bio Corporation (ANVS)|Net Profit GRCE|AIFF - Company Net Income|Klotho Neurosciences - Net Income|Profit After Payment of Taxes NRSN (NeuroSense Therapeutics Ltd)|Reviva Pharmaceuticals Holdings - Net Profit|NRXS - Net Profit|HSDT (heliusmedical.com) - Net Income|PASG (Passage Bio) - Company Net Income|NEUP (Neuphoria Therapeutics, Inc.) - Net Profit|Minerva Neurosciences Inc (NERV) - Net Financial Result|Net Profit ATHA|Net Profit Addex (ADXN)|Alzamend Neuro - Net Income|Final Profit CYCN|Protagenic - Net Profit|Net Financial Result Pasithea Therapeutics KTTA|cortigent.com (CRGT) - Company Net Income|Company Profit ATXI|BCLI (Brainstorm Cell) - Net Profit|Net Income caratherapeutics.com (CARA)|Company Net Income Chromocell Therapeutics Corp. (CHRO)|Net Income eliemtx.com ELYM|Intra-Cellular Therapies, Inc. - Net Income|Profit After Payment of Taxes LBPH (Longboard)|MRNS: Net Income|NKGN: Company Net Income|NRBO: Net Profit|Sage Therapeutics Inc. (SAGE) - Net Profit|Company Net Income Neurotrope|Company Profit TRVN (Trevena Inc)|Net Profit VIGL|WENA - Company Net Income|Cerevel Therapeutics, Inc. - Net Income